Gwyn Bebb, Senior Vice President, Global Therapeutic Area Head of Oncology at Parexel, shared a post on LinkedIn:
“As the year comes to a close, I’ve been reflecting on what sustained progress really looks like.
In oncology, meaningful impact isn’t driven by sudden bursts of speed — it’s built through discipline, direction, and the steady alignment of science, execution, and leadership.
This year reinforced an important truth:
when the course is clear and the fundamentals are strong, even the most complex journeys move forward with purpose.
Oncology continues to evolve at an extraordinary pace. The year ahead will require focus, resilience, and thoughtful leadership to translate innovation into real patient benefit.
Grateful for the teams and partners who continue to pull together — and energized by what lies ahead.”
More from Gwyn Bebb.